Crucially, the restoration of Galectin-9 expression completely countered the increase in ATXN3-null cancer cell growth (Figs. 4, A and B and S2), unequivocally demonstrating that ATXN3 executes its tumor-suppressive functions through the upregulation of Galectin-9. The gene discussed is LGALS9; the disease is cancer.